Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nilar intends to list the company's shares on Nasdaq First North Premier Growth Market

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, CANADA, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE IN ACCORDANCE WITH APPLICABLE LAW. Nilar International AB (publ) (“Nilar” or the “Company”), an innovative developer of batteries and electrical energy storage systems for stationary applications, today announces the intention to list the

Alzinova publishes the Annual Report for 2021

The Board of Directors and the Chief Executive Officer of Alzinova AB (publ) hereby present the Annual Report of the financial year 2020.The Annual Report, which is attached in the press release, can also be downloaded from the company’s Swedish website, www.alzinova.com/investors/financial-reports/   For more information, please contact:Kristina Torfgård, CEOtel: +46 708 46 79 75E-mail: kristina.torfgard@alzinova.com Håkan Skogström, CFOtel: +46 705 85 08 59E-mail: hakan.skogstrom@alzinova.com   About Alzinova ABAlzinova AB is a Swedish biopharma company

Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy

Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator’s proprietary patient specific immunotherapy Neo-X-Prime™ by incorporating MacroGenics’ proprietary DART[®] and TRIDENT[®] multi-specific platforms against two undisclosed targets.Under the

Keliber Upgraded the Process and Supplemented the EIA Report of the Kokkola Plant

The process of Keliber’s lithium chemical plant in Kokkola has been developed since the assessment report of the environmental impact assessment (EIA) procedure was completed on 6 March 2020. The company has now supplemented the EIA report to reflect the current project plan. The process changes apply to the treatment of effluent and analcime sand, which is a by-product created in the process. A supplemented EIA report was submitted to the ELY Centre of Southern Ostrobothnia on 31 March 2021. ELY will issue a supplemented reasoned conclusion on the report.According to the original plan,

Catella expands within Hospitality capital markets

Gustav Correll Bjørn joins Catella Corporate Finance capital markets team in Denmark with the aim of providing capital and liquidity to the Nordic hospitality sector addressing the current recapitalization needs, by introducing capital solutions and advisory services to the sector.The aim is to help current and future actors in the sector via sustainable and sound fresh capital solutions. In the long term, the platform will become a natural extension of Catella’s market-leading Corporate Finance operation, providing debt advisory and M&A services to the hospitality sector and the growth in

Invitation to presentation of BioArctic’s Interim Report for the period January - March 2021 on April 21 at 9.30 a.m. CET

Stockholm, Sweden, April 15, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will publish the company’s Interim Report for the period January – March 2021 on Wednesday, April 21, 2021, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on April 21, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the Interim Report for the period January – March 2021, followed by a Q&A-session. To attend, please dial-in at one of the numbers below,

Notice of annual general meeting in BONESUPPORT HOLDING AB

The shareholders in BONESUPPORT HOLDING AB (publ), Reg. No. 556802-2171, are hereby invited to attend the annual general meeting (Sw. årsstämma) to be held on Thursday 20 May 2021. The board of directors has, in light of the ongoing Corona pandemic, decided that the annual general meeting should be conducted by way of postal vote pursuant to temporary legislation being in effect in 2021. This means that the annual general meeting will be held without the physical presence of shareholders, representatives or third parties. The shareholders will therefore only be able to exercise their

Valio’s climate targets granted Science Based Targets certification -  Valio’s goal is to reset milk’s carbon footprint to zero by 2035

In 2020, Valio set science-based targets to reduce greenhouse gas emissions, and now, they have been accepted by the Science Based Targets initiative.* Valio is committed to limit the environmental impact of its production chain to an increase of no more than 1.5 degrees Celsius, in accordance with the Paris Climate Agreement. Dairy farm greenhouse emissions are monitored with the CARBO® environmental calculator. Over 600 dairy farms have already calculated their carbon footprint as a base for emissions reductions in the future.Set in summer 2020, Valio’s emission reduction targets to stop

Invitation to presentation of Midsona’s interim report on 29 April 2021

Midsona will publish its interim report January-March 2021 on 29 April 2021 at 8am CET. A presentation of the report will be held the same day at 11am CET via telephone conference or audio cast.Midsona invites investors, financial analysts, and media to a presentation where Managing Director and CEO Peter Åsberg and CFO Max Bokander will comment on the report. The presentation will be held at 11am CET and can be followed via telephone conference or audiocast. The report will be published at 8am CET and will be available at https://www.midsona.com/en/investors/reports/ The presentation

Nurminen Logistics expands its Asian routes to Yokohama, Japan, and opens two new destinations in China

Nurminen's train service, which started in 2018, has transported cargo from Helsinki and Narvik in Norway to various destinations in China and back. Due to enormously increased demand, the company is now expanding its rail routes to Japan. The company announced the Japan route opening at the international exhibition TransRussia in Moscow on April 12.The last train from Finland to Japan was more than 30 years ago. Nurminen Logistics train to Yokohama departs from Helsinki on April 15.The journey of more than 10,000 kilometers starts by train from Helsinki to Vostochny port in Nakhodka and

Nature article presents impact and importance of epithelial barrier damage on a range of common diseases.

STOCKHOLM, SWEDEN, — April 15, 2021 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a  groundbreaking article presenting the “epithelial barrier hypothesis” in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase’s product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases

Vicore Pharma publishes the Annual Report for 2020

Gothenburg, April 15, 2021 – Vicore Pharma Holding AB (publ), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today announced the publication of the Annual Report 2020.The Annual Report is available on the company’s website: https://vicorepharma.com/investors/financial-reports/ For further information, please contact: Hans Jeppsson, CFO, tel: +46 70 553 14 65, hans.jeppsson@vicorepharma.com   This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the

Basefarm signs agreement with Smartoptics to expand DCI capacity for Norwegian data centers

Oslo, Norway – April 15, 2021 – Smartoptics, a leading provider of optical networking solutions, announced today that European managed service provider Basefarm has signed an agreement with Smartoptics to upgrade its Norwegian fiber network. The new network will help Basefarm meet increasing needs for higher bandwidth and improve performance in its data storage service offering.To address customer needs in both the private and public sector, Basefarm decided to upgrade the data center interconnect for its three Norwegian data centers. The solution is based on the Smartoptics DCP-M40 

CLAVISTER HOLDING AB CONVENES ANNUAL GENERAL MEETING

The Clavister Holding AB board of directors has resolved to convene an annual general meeting of shareholders to be held on Tuesday, 19 May, 2020. Details on the proposals for the annual general meeting are found in the notice convening the meeting which is found below.  The notice will be published in Post- och inrikes Tidningar and on the company's website within the next few days.Notice of the annual general meeting of Clavister Holding AB Clavister Holding AB will hold its annual general meeting on Tuesday 18 May 2021. Due to the spread of covid-19, the board of directors has

Nilar avser att notera bolagets aktier på Nasdaq First North Premier Growth Market

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, I HELA ELLER DELAR, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, HONG KONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SYDAFRIKA, SYDKOREA, ELLER ANNAT LAND TILL JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING SKULLE VARA OTILLÅTEN ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER I ENLIGHET MED TILLÄMPLIG LAG. Nilar International AB (publ) (“Nilar” eller “Bolaget”), en innovativ leverantör av batterier och kompletta elektriska energilagringslösningar för stationära applikationer, offentliggör idag avsikten att

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 April 2021 at 9.00 EESTDuring the 1 February 2021 – 31 March 2021 conversion period there were three conversions and a total of 2 330 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 April 2021, and trading in the new R shares will start on 16 April 2021.Breakdown of shares after conversion:  A shares 176 251 985R shares 612 368 002Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 488 785.For

DNB ASA announces recommended voluntary cash offer by DNB Bank ASA for Sbanken ASA at NOK 103.85 per share

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 15 April 2021 – DNB ASA announces today that its wholly owned subsidiary DNB Bank ASA (“DNB” or the “Offeror”) has reached an agreement with Sbanken ASA (“Sbanken” or the “Company”), the Oslo Stock Exchange-listed company, to launch a recommended voluntary cash tender offer (the “Offer”) for 100% of the shares (the “Shares”) of the

TOMRA: Invitation to Q1 2021 Presentation

TOMRA's first quarter 2021 results will be released Friday 23 April 2021. President & CEO Stefan Ranstrand and CFO Espen Gundersen will present the results at 08:00 CEST (UTC+2). The presentation will be sent via live webcast. Questions to the speakers can be directed using the Q&A-tool embedded in the webcast and will be addressed towards the end of the presentation. A recorded version of the webcast will be available shortly after the webcast has concluded. Link to webcast will be available on www.tomra.com (Investor Relations section). All written materials including

QuickMIC® wins additional prestigious design award

Already a winner of the RedDot Design Award2021, Gradientech has been awarded this year’s iF DESIGN AWARD for its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing. The iF DESIGN AWARD is granted to products with outstanding design.The iF DESIGN AWARD is one of the most important design prizes in the world and recognized as an arbiter of quality for exceptional design. Gradientech´s QuickMIC product won in the Medicine/Health category.  “We are very proud to have received yet another design prize for our QuickMIC system. It really reiterates that we have

Stabilization notice

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES IN ACCORDANCE WITH APPLICABLE LAW. Pareto Securities AB (“Pareto Securities”) has notified LMK Group AB (publ) (“LMK Group” or the “Company”) that stabilization measures regarding the Company’s shares have been undertaken. As

Saga Pure ASA: Annual Report 2020

(Oslo, 15 April 2021) Saga Pure ASA (Saga Pure, OSE:SAGA) has published its Annual Report for 2020.The report is attached to this stock exchange notice and published on www.saga-pure.com.For further information, please contact: Bjørn Simonsen, CEO, +47 971 79 821 Espen Lundaas, CFO +47 92 43 14 17 About Saga Pure | www.saga-pure.comSaga Pure ASA is an investment company focusing on opportunities within renewable energy, hydrogen, circular economy and CO2-reduction. This stock exchange notice is subject to the disclosure requirements in Section 5-12 of the Norwegian

Invitation: Nixu Corporation’s Q1 2021 investor conference call on Apr 15 at 12.00 PM EEST

Nixu Corporation, Press release, April 15, 2021 at 8:35 AM EESTNixu Corporation published its revenue information, EBITDA and CEO’s review for January – March 2021 on April 15, 2021 at 8:30 AM EEST. The Stock exchange release is available on the company website at www.nixu.com/investors. Nixu will organize a conference call on April 15, 2021 at 12.00 PM EEST for analysts and investors. Petri Kairinen, Nixu CEO, will be hosting the event and available to answer questions. Registration Participants are requested to register for the event by contacting nixu.communications@nixu.com.

Nixu Corporation: CEO’s review for Q1 2021

Nixu Corporation, Stock Exchange release, April 15, 2021 at 8.30 AM EESTNixu Corporation’s unaudited revenue for January–March 2021 decreased by 6 % from the corresponding period of the previous year and amounted to EUR 13.1 million (Q1/2020: EUR 14.0 million). EBITDA increased to EUR 367 thousand (Q1/2020: EUR –365 thousand). Adjusted EBITDA was EUR 437 thousand (Q1/2020: EUR 8 thousand). Financial guidance for 2021 Nixu estimates its revenue to grow organically and its EBITDA to increase from 2020.Simultaneously investments to growth are increased. An investor conference call

Fiskars to publish its Interim Report for January-March 2021 on April 29, 2021

Fiskars CorporationPress releaseApril 15, 2021 at 08:00 (EET) Fiskars to publish its Interim Report for January-March 2021 on April 29, 2021 Fiskars Corporation will publish its Interim Report for January-March 2021 on April 29, 2021 at approximately 8:30 a.m. (EET). The Interim Report will be available on the company's website www.fiskarsgroup.com after publication. WebcastA webcast on the first quarter results will be held on April 29, 2021 at 11:00 a.m. It will be held in English and can be followed at: https://fiskars.videosync.fi/fiskars-group-q1-results Presentation

There are no items matching the current filter
There are no more items matching the current filter
Back to top